International immunopharmacologyAnimalsMyocardial InfarctionMolecular Docking SimulationNetwork PharmacologyDrugs
A comprehensive strategy of network pharmacology and molecular docking reveals Danshenol a as a main active component of Huoluoxiaolingdan in ameliorating acute myocardial infarction.
Tao Geng, Lei Zhang, Guifang Liu, Die Lin
Published: 202610.1016/j.intimp.2025.115955
Abstract
BACKGROUND: Acute myocardial infarction (AMI) remains the principal contributor to global mortality, necessitating the development of effective therapeutic interventions. Huoluoxiaolingdan (XLD), a well-known traditional Chinese medicine formulation,…
Preview only. Read the full abstract at the source